Page last updated: 2024-09-05

sorafenib and Leukemia, Acute Monocytic

sorafenib has been researched along with Leukemia, Acute Monocytic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kearns, PR; Knapper, S; Moore, AS; Pearson, AD; Zwaan, CM1
Li, QH; Liu, BC; Liu, KQ; Mi, YC; Wang, JX; Wei, H; Wei, SN; Zhou, CL1
Hayasaka, K; Kanno, M; Kawakami, T; Mitsui, T; Onoda, T; Sato, H; Takahashi, N1

Reviews

2 review(s) available for sorafenib and Leukemia, Acute Monocytic

ArticleYear
Novel therapies for children with acute myeloid leukaemia.
    Leukemia, 2013, Volume: 27, Issue:7

    Topics: Adenine Nucleotides; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Child; Clofarabine; Gemtuzumab; Humans; Immunotoxins; Leukemia, Monocytic, Acute; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib

2013
[Sorafenib in combination with chemotherapy in the induction therapy for FLT3-ITD positive acute monocytic leukemia: a case report and literature review].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Monocytic, Acute; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib

2011

Other Studies

1 other study(ies) available for sorafenib and Leukemia, Acute Monocytic

ArticleYear
[Successful treatment with sorafenib for primary refractory acute monoblastic leukemia with FLT3-ITD].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Fatal Outcome; fms-Like Tyrosine Kinase 3; Humans; Inverted Repeat Sequences; Leukemia, Monocytic, Acute; Male; Niacinamide; Phenylurea Compounds; Sorafenib

2012